Sirtex Medical   Report issue

For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Woburn MA United States (2001)
Status: No NME R&D (2001)

Organization Overview

First Clinical Trial
2006
NCT00604409
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Sirtex Medical

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma (Phase 3)

Carcinoma, Hepatocellular (Phase 3)

Cholangiocarcinoma (Phase 3)

Colonic Neoplasms (Phase 2)

Colorectal Neoplasms (Phase 3)

Liver Diseases (Phase 2)

Liver Neoplasms (Phase 3)

Neoplasm Metastasis (Phase 3)

Neoplasms, Second Primary (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 18
  • # of Trial APIs: 23